Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads

Clinical and Experimental Medicine

Volumn 12, Issue 3, 2012, Pages 145-151

  Zhang, Xiaoxue ^a   Yuan, Zhaolin ^a   Shen, Bo ^a   Zhu, Min ^a   Liu, Chibo ^b   Xu, Wei ^a  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^b TAIZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

Biomarkers; Diagnostic model; MALDI TOF MS; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; PROTEOME; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; CATION EXCHANGE; COMPUTER PROGRAM; CONTROLLED STUDY; DEVICES; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEOMICS; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; WEAK CATIONIC EXCHANGE MAGNETIC BEAD;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAGNETS; MALE; MIDDLE AGED; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFTWARE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84865462611     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-011-0154-5     Document Type: Article

References (31)

1. IE Hoffman I Peene H Pottel, et al. 2005 Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis Clin Chem 51 261 263 15388633 10.1373/clinchem.2004.034728 1:CAS:528:DC%2BD2MXlt1yrsA%3D%3D
2. T Pincus T Sokka 2009 Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations Rheum Dis Clin North Am 35 731 734 19962617 10.1016/j.rdc.2009.10.007
3. G Steiner J Smolen 2002 Autoantibodies in rheumatoid arthritis and their clinical significance Arthritis Res 4 S1 S5 12110150 10.1186/ar551
4. AN Lee CE Beck M Hall 2008 Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review Clin Lab Sci 21 15 18 18335856 1:CAS:528:DC%2BD1cXosVKrt7o%3D
5. P Maurya P Meleady P Dowling, et al. 2007 Proteomic approaches for serum biomarker discovery in cancer Anticancer Res 27 1247 1255 17593616 1:CAS:528:DC%2BD2sXmslKju7s%3D
6. A Gámez-Pozo I Sánchez-Navarro M Nistal, et al. 2009 MALDI profiling of human lung cancer subtypes PLoS One 4 e7731 19890392 10.1371/journal.pone.0007731
7. L Shi J Zhang P Wu, et al. 2009 Discovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia Proteome Sci 7 7 19291297 10.1186/1477-5956-7-7
8. X Zhang T Guo H Wang, et al. 2008 Potential biomarkers of acute cerebral infarction detected by SELDI-TOF-MS Am J Clin Pathol 130 299 304 18628101 10.1309/CA242R5VY14HUGE8 1:CAS:528:DC%2BD1cXhtVegtbnN
9. Zhou M, Veenstra T (2008) Mass spectrometry: m/z 1983-2008. Biotechniques 44:667-668, 670
10. K Sparbier T Wenzel H Dihazi, et al. 2009 Immuno-MALDI-TOF-MS: new perspectives for clinical applications of mass spectrometry Proteomics 9 1442 1450 19235164 10.1002/pmic.200800616 1:CAS:528:DC%2BD1MXksVKru74%3D
11. P Wang JR Whiteaker AG Paulovich 2009 The evolving role of mass spectrometry in cancer biomarker discovery Cancer Biol Ther 8 1083 1094 19502776 1:CAS:528:DC%2BD1MXhs1ahtrbN
12. M Pietrowska L Marczak J Polanska, et al. 2009 Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer J Transl Med 7 60 19594898 10.1186/1479-5876-7-60
13. R Guo C Pan J Shen, et al. 2011 New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry J Cancer Res Clin Oncol 137 513 519 20490864 10.1007/s00432-010-0899-3 1:CAS:528:DC%2BC3MXhvV2hs7s%3D
14. QT Wang YZ Li YF Liang, et al. 2009 Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software Anat Rec (Hoboken) 292 604 610 10.1002/ar.20871
15. J Marshall P Kupchak W Zhu, et al. 2003 Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction J Proteome Res 2 361 372 12938926 10.1021/pr030003l 1:CAS:528:DC%2BD3sXjs1Gnurs%3D
16. Breiman L, Friedman JH, Olshen RA, Stone CJ (1984) Classification and regression trees. Wadsworth, Belmont
17. RF Van Vollenhoven 2009 Treatment of rheumatoid arthritis: state of the art 2009 Nat Rev Rheumatol 5 531 541 19798027 10.1038/nrrheum.2009.182
18. SC Wong CM Chan BB Ma, et al. 2009 Advanced proteomic technologies for cancer biomarker discovery Expert Rev Proteomics 6 123 134 19385940 10.1586/epr.09.1 1:CAS:528:DC%2BD1MXkvFKhsr8%3D
19. M Choolani K Narasimhan V Kolla, et al. 2009 Proteomic technologies for prenatal diagnostics: advances and challenges ahead Expert Rev Proteomics 6 87 101 19210129 10.1586/14789450.6.1.87 1:CAS:528:DC%2BD1MXhslyis7k%3D
20. T Wu C Mohan 2009 Proteomic toolbox for autoimmunity research Autoimmun Rev 8 595 598 19393208 10.1016/j.autrev.2009.01.019 1:CAS:528: DC%2BD1MXovFaqsLo%3D
21. MT Kelleher G Fruhwirth G Patel, et al. 2009 The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients Target Oncol 4 235 252 19756916 10.1007/s11523-009-0116-y
22. JF Peter AM Otto 2010 Magnetic particles as powerful purification tool for high sensitive mass spectrometric screening procedures Proteomics 10 628 633 20099258 10.1002/pmic.200900535 1:CAS:528:DC%2BC3cXis1ekur8%3D
23. JR Whiteaker L Zhao HY Zhang, et al. 2007 Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers Anal Biochem 362 44 54 17241609 10.1016/j.ab.2006.12.023 1:CAS:528:DC%2BD2sXhs1Cnsr8%3D
24. YZ Li CJ Hu XM Leng, et al. 2009 Promising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI-TOF-MS Anat Rec (Hoboken) 292 455 460 10.1002/ar.20870 1:CAS:528:DC%2BD1MXktFCnsrs%3D
25. H Visser S le Cessie K Vos, et al. 2002 How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis Arthritis Rheum 46 357 365 11840437 10.1002/art.10117
26. V Goëb M Thomas-L'Otellier R Daveau, et al. 2009 Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes Arthritis Res Ther 11 R38 19284558 10.1186/ar2644
27. Z Huang Y Shi B Cai, et al. 2009 MALDI-TOF-MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus Rheumatology (Oxf) 48 626 631 10.1093/rheumatology/kep058 1:CAS:528:DC%2BD1MXmtFCjtL8%3D
28. R Komurasaki S Imaoka N Tada, et al. 2010 LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylester-ase 1 and CYP2D6 Drug Metab Pharmacokinet 25 84 92 20208391 10.2133/dmpk.25.84 1:CAS:528: DC%2BC3cXlsVSmurk%3D
29. L Giusti C Baldini L Bazzichi, et al. 2007 Proteomic diagnosis of Sjögren's syndrome Expert Rev Proteomics 4 757 767 18067414 10.1586/14789450.4.6.757 1:CAS:528:DC%2BD2sXhsVSjtrvL
30. T Uchida A Fukawa M Uchida, et al. 2002 Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid J Proteome Res 1 495 499 12645617 10.1021/pr025531w 1:CAS:528:DC%2BD38XntVahur8%3D
31. D de Seny M Fillet MA Meuwis, et al. 2005 Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteinchip approach Arthritis Rheum 52 3801 3812 16320331 10.1002/art.21607